Phenotypic and Genetic Characterization of a Unique Variant of Serogroup C ET-15 Meningococci (with the Antigenic Formula C:2a:P1.7,1) Causing Invasive Meningococcal Disease in Quebec, Canada

Journal of Clinical Microbiology

Volumn 42, Issue 4, 2004, Pages 1460-1465

  Tsang, Raymond S W ^a   Tsai, Chao Ming ^c   Zhu, Peixuan ^c,d   Ringuette, Louise ^b   Lorange, Manon ^b   Law, Dennis K S ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d CREATV MICROTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGENICITY; ARTICLE; BLOOD GROUP TYPING; CANADA; CLONAL VARIATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HOUSEKEEPING GENE; MENINGOCOCCOSIS; MULTILOCUS ENZYME ELECTROPHORESIS; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; VIRUS CHARACTERIZATION;

ANTIGENIC VARIATION; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; GENOTYPE; HUMANS; LIPOPOLYSACCHARIDES; MENINGOCOCCAL INFECTIONS; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS, SEROGROUP C; PHENOTYPE; PORINS; QUEBEC; SEROTYPING;

ANIMALIA; NEGIBACTERIA; NEISSERIA; NEISSERIA MENINGITIDIS;

EID: 2942532062     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.4.1460-1465.2004     Document Type: Article

References (39)

1. Abdillahi, H., and J. T. Poolman. 1987. Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48: 367-371.
2. Ashton, F. E., J. A. Ryan, A. Borczuk, D. A. Caugant, L. Mancino, and D. Huang. 1991. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J. Clin. Microbiol. 29:2489-2493.
3. Ashton, F. E., and D. A. Caugant. 2001. The panmictic nature of Neisseria meningitidis serogroup B during a period of endemic disease in Canada. Can. J. Microbiol. 47:283-289.
4. Brundage, J. F., M. A. K. Ryan, B. H. Feighner, and F. J. Erdtmann. 2002. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998. Clin. Infect. Dis. 35:1376-1381.
5. Caugant, D. A. 1998. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 106:505-525.
6. De Wals, P., M. Dionne, M. Douville-Fradet, N. Boulianne, J. Drapeau, and G. De Serres. 1996. Impact of a mass immunization campaign against serogroup C meningococcus in the province of Québec, Canada. Bull. W. H. O. 74:407-411.
7. De Wals, P., G. De Serres, and T. Niyonsenga. 2001. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Québec. JAMA 285:177-181.
8. Erickson, L., and P. De Wals. 1984. Complications and sequelae of meningococcal disease in Québec, Canada, 1990-1994. Clin. Infect. Dis. 26:1159-1164.
9. Feavers, I. M., A. B. Heath, J. A. Bygraves, and M. C. J. Maiden. 1992. Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis. Mol. Microbiol. 6:489-495.
10. Frasch, C. E., W. D. Zollinger, and J. T. Poolman. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:504-510.
11. Gu, X. X., and C. M. Tsai. 1991. Purification of rough-type lipopolysaccharides of Neisseria meningitidis from cells and outer membrane vesicles in spent media. Anal. Biochem. 196:311-318.
12. Guillemette, P., B. Fournier, and Y. Robert. 1991. A cluster of Neisseria meningitidis cases in Québec, January 1991. Can. Dis. Wkly. Rep. 17:295-296.
13. Jelfs, J., R. Munro, F. E. Ashton, and D. A. Caugant. 2000. Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol. Infect. 125:285-298.
14. Kuipers, B., G. van den Dobbelsteen, E. Wedege, and L. Van Alphen. 2001. Serological characterization, p. 131-145. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease: methods and protocols. Humana Press, Totowa, N.J.
15. Lavigne, P., N. Boulianne, C. Fortin, H. Accache, and M. Douville-Fradet. 1992. Meningococcal infections in Québec, 1991-1992. Can. Commun. Dis. Rep. 18:113-116.
16. Maiden, M. C. J., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and R. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95:3140-3145.
17. McCguinness, B. T., P. R. Lambden, and J. K. Heckels. 1993. Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol. Microbiol. 7:505-514.
18. Peron, L., and C. Laferriere. 1991. Four cases of Neisseria meningitidis infection linked to frequenting a bar C Québec. Can. Dis. Wkly. Rep. 17:294-295.
19. Pollard, A. J., T. W. S. Tam, and the National Advisory Committee on Immunization. 2001. Advisory Committee statement on recommended use of meningococcal vaccines. Can. Commun. Dis. Rep. 27:2-36.
20. Poolman, J. T., P. A. van der Ley, and J. Tommassen. 1995. Surface structures and secreted products of meningococci, p. 21-34. In K. A. V. Cartwright, (ed.), Meningococcal disease. John Wiley & Sons, Inc., New York, N.Y.
21. Ringuette, L., M. Lorange, A. Ryan, and F. Ashton. 1995. Meningococcal infections in the province of Québec, Canada, during the period 1991 to 1992. J. Clin. Microbiol. 33:53-57.
22. Sacchi, C. T., A. P. S. Lemon, A. M. Whitney, C. A. Solari, M. E. Brandt, C. E. A. Melles, C. E. Frasch, and L. W. Mayer. 1998. Correlation between serological and sequence analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping scheme. Clin. Diagn. Lab. Immunol. 5:348-354.
23. Sacchi, C. T., A. P. S. Lemos, M. E. Brandt, A. M. Whitney, C. E. A. Melles, C. A. Solari, C. E. Frasch, and L. W. Mayer. 1998. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin. Diagn. Lab. Immunol. 5:845-855.
24. Sacchi, C. T., A. M. Whitney, T. Popovic, D. S. Beall, M. W. Reeves, B. D. Plikaytis, N. E. Rosentein, B. A. Perkins, M. L. C. Tondella, and L. W. Mayer. 2000. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J. Infect. Dis. 182:1169-1176.
25. Selander, R. K., D. A. Caugant, H. Ochman, J. M. Musser, M. N. Gilmour, and T. S. Whittam. 1986. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl. Environ. Microbiol. 51:873-884.
26. Tondella M. L. C., T. Popovic, N. E. Rosentein, D. B. Lake, G. M. Carlone, L. W. Mayer, B. A. Perkins, and the Active Bacterial Core Surveillance Team. 2000. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. J. Clin. Microbiol. 38:3323-3328.
27. Tsai, C. M., L. F. Mocca, and C. E. Frasch. 1987. Immunotype epitopes of Neisseria meningitidis lipopolysaccharide types 1 through 8. Infect. Immun. 55:1652-1656.
28. Tsai, C. M., W. H. Chen, and P. A. Balakonis. 1998. Characterization of terminal NeuNAcα 2-3Galβ1-4GlcNAc sequence in lipooligosaccharides of Neisseria meningitidis. Glycobiology 8:359-365.
29. Tsang, R. S. W., S. G. Squires, W. D. Zollinger, and F. E. Ashton. 2002. Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada. January 1, 1999 to June 30, 2001. Can. J. Infect. Dis. 13:391-396.
30. Tsang, R. S. W., L. Kiefer, D. K. S. Law, J. Stoltz, R. Shahin, S. Brown, and F. Jamieson. 2003. Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men. J. Clin. Microbiol. 41:4411-4414.
31. Tsang, R. S. W., S. G. Squires, and T. W. S. Tam. 2003. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001. Can. J. Microbiol. 49:633-638.
32. Tyrrell, G. J., L. Chiu, M. Johnson, N. Chang, R. P. Rennie, and J. A. Talbot. 2002. Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada. Emerg. Infect. Dis. 8:519-521.
33. Varughese, P. V., and A. O. Carter. 1983. Meningococcal disease in Canada and serogroup distribution. Can. Dis. Wkly. Rep. 9:177-180.
34. Vazquez, J. A., S. Berron, M. O'Rourke, G. Carpenter, E. Feil, N. H. Smith, and B. G. Spratt. 1995. Interspecies recombination in nature: a meningococcus that has acquired a gonococcal PIB porin. Mol. Microbiol. 15:1001-1007.
35. Vedros, N. A. 1987. Development of meningococcal serogroups, p. 33-37. In N. A. Vedros (ed.), Evolution of meningococcal disease. CRC Press, Boca Raton, Fla.
36. Vogel, U., H. Claus, M. Frosch, and D. A. Caugant. 2000. Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J. Clin. Microbiol. 38:941-942.
37. Wang, J. F., D. A. Caugant, G. Morelli, B. Koumare, and M. Achtman. 1993. Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J. Infect. Dis. 167:1320-1329.
38. Whalen, C. M., J. C. Hockin, A. Ryan, and F. Ashton. 1995. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. JAMA 273:390-394.
39. Zhu, P., M. J. Klutch, M. C. Bash, R. S. W. Tsang, L. K. Ng, and C. M. Tsai. 2002. Genetic diversity of three lgt loci for biosynthesis of LOS in Neisseria species. Microbiology 148:1833-1844.